(Q78025040)
Statements
Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity (English)
Mineishi S
Longo WL
Atkinson ME
Smith EP
Hamielec M
Wiersma SR
Kinsella TJ
Schuening FG